The bottom line is that the rate of growth in deaths continued lower in the US and across Europe over the weekend. Most countries have seen an improvement except Singapore, where cases in dormitories keep rising, and Russia, which is lagging in the virus cycle. Focus is now on the reopening of Germany and some US states joining in a moderate easing of restrictions. All eyes will also be on upcoming trial reports on the Remdesivir drug, where a leak last week hinted at promising results.
